Neogen Co. (NASDAQ:NEOG - Get Free Report) insider Amy M. Rocklin bought 12,500 shares of the firm's stock in a transaction on Wednesday, April 23rd. The shares were bought at an average price of $4.99 per share, for a total transaction of $62,375.00. Following the completion of the transaction, the insider now directly owns 36,287 shares in the company, valued at approximately $181,072.13. This represents a 52.55 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available through this link.
Neogen Stock Performance
Shares of NEOG opened at $4.92 on Thursday. The company has a 50-day moving average of $8.20 and a two-hundred day moving average of $11.38. The stock has a market cap of $1.07 billion, a P/E ratio of -2.25 and a beta of 1.57. Neogen Co. has a 12-month low of $3.87 and a 12-month high of $18.58. The company has a current ratio of 3.77, a quick ratio of 2.46 and a debt-to-equity ratio of 0.33.
Neogen (NASDAQ:NEOG - Get Free Report) last posted its earnings results on Wednesday, April 9th. The company reported $0.10 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.02). The company had revenue of $221.00 million during the quarter, compared to analysts' expectations of $225.27 million. Neogen had a negative net margin of 52.12% and a positive return on equity of 2.89%. Neogen's quarterly revenue was down 3.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.12 EPS. As a group, research analysts predict that Neogen Co. will post 0.38 EPS for the current fiscal year.
Institutional Trading of Neogen
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Norges Bank purchased a new position in shares of Neogen during the fourth quarter valued at approximately $212,171,000. Vanguard Group Inc. lifted its position in Neogen by 9.8% during the fourth quarter. Vanguard Group Inc. now owns 21,637,251 shares of the company's stock worth $262,676,000 after buying an additional 1,928,491 shares during the period. Private Advisor Group LLC boosted its stake in Neogen by 135.3% in the 4th quarter. Private Advisor Group LLC now owns 67,298 shares of the company's stock worth $817,000 after buying an additional 38,703 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Neogen by 2.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,061,927 shares of the company's stock valued at $25,032,000 after buying an additional 52,663 shares during the period. Finally, Pictet Asset Management Holding SA increased its stake in shares of Neogen by 26.9% during the 4th quarter. Pictet Asset Management Holding SA now owns 2,369,595 shares of the company's stock valued at $28,767,000 after acquiring an additional 501,957 shares during the last quarter. Hedge funds and other institutional investors own 96.73% of the company's stock.
Analyst Ratings Changes
Several brokerages have weighed in on NEOG. Piper Sandler lowered their target price on shares of Neogen from $6.40 to $5.00 and set a "neutral" rating on the stock in a research report on Tuesday. Guggenheim decreased their target price on Neogen from $15.00 to $13.00 and set a "buy" rating on the stock in a research report on Thursday, April 10th.
Check Out Our Latest Research Report on Neogen
Neogen Company Profile
(
Get Free Report)
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
